Thrivent Financial for Lutherans’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-129,535
| Closed | -$644K | – | 2430 |
|
|
2023
Q2 | $644K | Sell |
129,535
-160,972
| -55% | -$800K | ﹤0.01% | 2074 |
|
|
2023
Q1 | $1.44M | Sell |
290,507
-166,369
| -36% | -$822K | ﹤0.01% | 1548 |
|
|
2022
Q4 | $2.87M | Buy |
456,876
+290,286
| +174% | +$1.83M | 0.01% | 1030 |
|
|
2022
Q3 | $1.8M | Buy |
166,590
+123,176
| +284% | +$1.33M | ﹤0.01% | 1284 |
|
|
2022
Q2 | $494K | Sell |
43,414
-37,873
| -47% | -$431K | ﹤0.01% | 2098 |
|
|
2022
Q1 | $740K | Sell |
81,287
-75,052
| -48% | -$683K | ﹤0.01% | 1998 |
|
|
2021
Q4 | $2.33M | Buy |
156,339
+102,160
| +189% | +$1.52M | ﹤0.01% | 1284 |
|
|
2021
Q3 | $1.39M | Buy |
54,179
+12,824
| +31% | +$329K | ﹤0.01% | 1612 |
|
|
2021
Q2 | $1.08M | Buy |
+41,355
| New | +$1.08M | ﹤0.01% | 1788 |
|